SLAM-Scams~Lies~Alerts/Recalls~Myths

#-9-0 Phone Scam (Mostly False)

Best rule of thumb when strangers ask you to dial, transfer or call another number is to JUST DON'T DO IT!

And remember the greatest rule of thumb of all, "If it sounds too good to be true, it probably is"!

So bottom line is this scam does not affect residential or cell phone customers-it only applies to businesses, hospitals, government agencies and other organizations that still use telephone private branch exchanges (PBXs) rather than Centrex lines to handle their calls.

So, if you have these lines where you work, DO NOT TRANSFER ANYONE, EVER, TO AN OUTSIDE LINE.

For any further question feel free to leave me a comment and I will respond.


I always so my best to track down the scams and rumors by using reputable sites that do the research to make sure that we all get the facts straight when it comes to scams, tricks, myths and computer viruses information etc.

RECALL-ALERT
Piperacillin and Tazobactam for Injection, USP 40.5 grams: STOP USING

Piperacillin and Tazobactam for Injection, USP 40.5 grams: Recall - Precipitation or Crystallization in IV Bag or IV Line Upon Reconstitution

*AUDIENCE*: Risk Manager, Nursing, Health Professional

*ISSUE*: Apotex Corp. notified healthcare professionals it is conducting, on behalf of the manufacturer Hospira, Inc., a voluntary nationwide recall of 15 lots of Piperacillin and Tazobactam for Injection, USP 40.5 grams, to the hospital/healthcare provider/user level. The impacted lots may show precipitation/ crystallization in IV bag or IV line after reconstitution.

Hospira stated that administration of precipitated Piperacillin/Tazobactam in an IV bag or IV line may result in local reactions such as phlebitis, renal impairment, end-organ embolism and ischemia, and/or vasculitis (because the precipitate was visible, its particles may be large enough to cause these adverse events). In addition, the precipitation of the drug may not allow delivering a needed therapeutic dose of piperacillin and tazobactam, thus resulting in inadequate treatment of the targeted infection. This could result in adverse health consequences that could range from transient and minor impairment or complaints to permanent impairment of a body function or permanent damage to a body structure.

Read the MedWatch safety alert, including a link to the Press Release, at:

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm350085.htm [http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm350085.htm?source=govdelivery ]

FDA MedWatch - LifeScan, Inc.OneTouch Verio IQ Blood Glucose Meter - Recall:

*LifeScan, Inc. OneTouch Verio IQ Blood Glucose Meter –Class I Recall: Failure to Provide a Warning at Extremely High Blood

*AUDIENCE*: Consumer, Health Professional, Pharmacy

*ISSUE*: At extremely high blood glucose levels of 1024 mg/dL and above, the OneTouch Verio IQ Meter will turn off instead of displaying the message “EXTREME HIGH GLUCOSE above 600 mg/dL” as intended. When turned back on, the meter enters the “Set-Up” mode and requires the user to confirm the date and time settings before being able to test again. However, if the glucose level is still measuring1024 mg/dL or above when testing, the meter will shut down again.

Read the complete MedWatch Safety Alert, including a link to the Recall Notice, at:

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm349187.htm[ http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm349187.htm?source=govdelivery]